首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli.
【2h】

Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli.

机译:抗体结合位点的蛋白质工程:在大肠杆菌中产生的抗地高辛单链Fv类似物的比活性恢复。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A biosynthetic antibody binding site, which incorporated the variable domains of anti-digoxin monoclonal antibody 26-10 in a single polypeptide chain (Mr = 26,354), was produced in Escherichia coli by protein engineering. This variable region fragment (Fv) analogue comprised the 26-10 heavy- and light-chain variable regions (VH and VL) connected by a 15-amino acid linker to form a single-chain Fv (sFv). The sFv was designed as a prolyl-VH-(linker)-VL sequence of 248 amino acids. A 744-base-pair DNA sequence corresponding to this sFv protein was derived by using an E. coli codon preference, and the sFv gene was assembled starting from synthetic oligonucleotides. The sFv polypeptide was expressed as a fusion protein in E. coli, using a leader derived from the trp LE sequence. The sFv protein was obtained by acid cleavage of the unique Asp-Pro peptide bond engineered at the junction of leader and sFv in the fusion protein [(leader)-Asp-Pro-VH-(linker)-VL]. After isolation and renaturation, folded sFv displayed specificity for digoxin and related cardiac glycosides similar to that of natural 26-10 Fab fragments. Binding between affinity-purified sFv and digoxin exhibited an association constant [Ka = (3.2 +/- 0.9) x 10(7) M-1] that was about a factor of 6 smaller than that found for 26-10 Fab fragments [Ka = (1.9 +/- 0.2) x 10(8) M-1] under the same buffer conditions, consisting of 0.01 M sodium acetate, pH 5.5/0.25 M urea.
机译:通过蛋白质工程在大肠杆菌中产生了生物合成抗体结合位点,该位点在单个多肽链中掺入了抗地高辛单克隆抗体26-10的可变域(Mr = 26,354)。该可变区片段(Fv)类似物包含通过15个氨基酸接头连接的26-10个重链和轻链可变区(VH和VL),以形成单链Fv(sFv)。 sFv被设计为248个氨基酸的脯氨酰-VH-(接头)-VL序列。通过使用大肠杆菌密码子首选项获得对应于该sFv蛋白的744个碱基对的DNA序列,并从合成寡核苷酸开始组装sFv基因。 sFv多肽使用衍生自trp LE序列的前导序列在大肠杆菌中表达为融合蛋白。 sFv蛋白是通过酸解融合蛋白[(leader)-Asp-Pro-VH-(linker)-VL]的前导序列和sFv交界处工程化的独特Asp-Pro肽键而获得的。分离和复性后,折叠的sFv对地高辛和相关强心苷显示出与天然26-10 Fab片段相似的特异性。亲和纯化的sFv和地高辛之间的结合表现出缔合常数[Ka =(3.2 +/- 0.9)x 10(7)M-1],比26-10 Fab片段[Ka]约小6倍。 =(1.9 +/- 0.2)×10(8)M-1],在相同的缓冲条件下,由0.01M乙酸钠,pH 5.5 / 0.25M尿素组成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号